Gene Fusion Testing Market, By Indication (Hematological Malignancies, Solid Tumors), By Technology (FISH, NGS, PCR, IHC), By End-Users (Hospitals, Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, Academic & Research Centers), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2032

Report Code: PMI516423 | Publish Date: November 2023 | No. of Pages: 170

Gene Fusion Testing Market Overview

[PDF] Gene Fusion is defined as joining of two genes which are transcribed and translated as a single unit. Gene fusion testing are used in cancer diseases, whereas the advancement in NGS (next generation sequencing) have revolutionized the estimation and characterization of fusion genes in oncology.

Gene Fusion Testing Market Size:

Attributes

Details

Gene Fusion Testing Market Value (2022)

US$ 255.3Mn

Gene Fusion Testing Market Projected Value (2032)

US$ 794.0Mn

Gene Fusion Testing Market CAGR (2022 – 2032)

12.5%

Gene Fusion Testing Market Dynamics

Growing Prevalence of Cancer Diseases to fuel market growth

Growing prevalence of cancer diseases has become major driving factor in market growth. Rapid growth in urbanization coupled with adoption of unhealthy lifestyle and poor nutrition food has given positive impact on Gene Fusion Testing Market growth. Rising cancer diseases led to rise in demand for advanced diagnostic techniques to effective treatment which in turn, facilitate the demand for Gene Fusion Testing market growth. The gene fusion testing is a molecular diagnostic method used for identifying and analyzing the distinct genetic alterations in cancer cells which is likely to propel market growth.

For instance, according to CDC (Centers for Disease Control and Prevention) in 2019, around 1,752,735 new cancer cases were reported and 599,589 people were died of cancer disease in United States of America.

Restrains:

The high complexity of testing process has restrained market growth. Further, lack of standardization and reimbursement barriers have hampered the demand for Gene Fusion Testing Market growth.

Access Crucial Insights at a Fraction of the Cost | Request Your Discount

Gene Fusion Testing Market Segmentation

Gene Fusion Testing Market is segmented based on Indication, Technology, End-Users and Region.

Indication Insight

On the basis of Indication, Gene Fusion Testing Market is segmented into Hematological Malignancies, Solid Tumors.

Technology Insight

On the basis of Technology, Gene Fusion Testing Market is segmented into FISH (Fluorescence in Situ Hybridization), NGS (Next-Generation Sequencing), PCR (Polymerase Chain Reaction), IHC (Immunohistochemistry).

End-Users Insights

On the basis of End-Users, Gene Fusion Testing Market is segmented into Hospitals, Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, Academic & Research Centers.

Gene Fusion Testing Market Regional Insights:

On region the Gene Fusion Testing Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

North America market is estimated to witness a significantly high revenue share over the forecast period due to rising prevalence of cancer diseases, continuous technological development, presence of major players and advancement in diagnostic testing.

Reduce costs by up to 30% with a custom report tailored to your specific needs | Request Customized Report

Recent Development:

The New Launched Product News,

  • In January 2023, Arima Genomics announced an agreement with Protean BioDiagnostics to develop NGS-based (next generation sequencing) gene fusion testing service. The new gene fusion testing service by using Arima’s novel genomic technology will help in identifying the clinically actionable gene fusions in patients with tumor tissues.
  • In March 2021, Biocartis launched new rapid lab workflow solution ‘Idylla GeneFusion Assay’ for gene fusion testing. The new launched assay help in detecting various gene fusions that are relevant in cancer research in a single cartridge.

Report Scope:

Attribute

Details

Base year for estimation

2022

Forecast period

2022 – 2032

Market representation

Revenue in USD Million & CAGR from 2022 to 2032

Market Segmentation

By Indication - Hematological Malignancies, Solid Tumors

By Technology - FISH (Fluorescence in Situ Hybridization), NGS (Next-Generation Sequencing), PCR (Polymerase Chain Reaction), IHC (Immunohistochemistry)

By End-Users - Hospitals, Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, Academic & Research Centers

Regional scope

North America - U.S., Canada

Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe

Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific

Latin America - Brazil, Mexico, Argentina, Rest of Latin America

Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2022 to 2032.

Few Other Promising Reports:

Gene Fusion Testing Market Key Players

The key players operating the Gene Fusion Testing Market includes, Amoy Diagnostics Co. Ltd., Arima Genomics, F. Hoffman-La Roche Ltd., ArcherDX, Biocartis, Illumina, Danaher Corporation, Guardant Health, Biocare Medical LLC., and Myriad Genetics Inc.

Gene Fusion Testing Market Company Profile

  • Amoy Diagnostics Co. Ltd.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Arima Genomics
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • F. Hoffman-La Roche Ltd.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • ArcherDX
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Biocartis
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Illumina
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Danaher Corporation
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Guardant Health
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Biocare Medical LLC.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Myriad Genetics Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  1. The Last Word
    • Future Impact
    • About Us
    • Contact

Gene Fusion Testing Market Table of Contents

  1. Research Objective and Assumption
    • Preface
    • Research Objectives
    • Study Scope
    • Years Considered for the study
    • Assumptions
    • Abbreviations
  2. Research Methodology
    • Research data
    • Primary Data
      • Primary Interviews
      • Primary Breakdown
      • Key data from Primary Sources
      • Key Thickness Insights
    • Secondary Data
      • Major Secondary Sources
      • Secondary Sources
    • Market Estimation
    • Top-Down Approach
      • Approach for estimating Market Share by Top-Down Analysis (Supply Side)
    • Bottom-Up Approach
      • Approach for estimating market share by Bottom-up Analysis (Demand Side)
    • Market Breakdown and Data Triangulation
    • Research Assumptions
  3. Market Purview
    • Executive Summary
    • Key Findings—Global Outlook for medical carts Strategies
      • Key Questions this Study will Answer
      • Market Snippet, By Indication
      • Market Snippet, By Technology
      • Market Snippet, By End-Users
      • Market Snippet, By Region
    • Opportunity Map Analysis
    • Executive Summary—3 Big Predictions
  4. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restrains
      • Market Opportunities
      • Market Trends
    • DR Impact Analysis
    • PEST Analysis
    • Porter’s Five Forces Analysis
    • Opportunity Orbit
    • Market Investment Feasibility Index
    • Macroeconomic Factor Analysis
  5. Gene Fusion Testing Market, By Indication, Forecast Period up to 10 Years, (US$ Mn)
  • Overview
    • Market Value and Forecast (US$ Mn), and Share Analysis (%), Forecast Period up to 10 Years
    • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
    • Segment Trends
  • Hematological Malignancies
    • Overview
    • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Solid Tumors
    • Overview
    • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  1. Gene Fusion Testing Market, By Technology, Forecast Period up to 10 Years, (US$ Mn)
  • Overview
    • Market Value and Forecast (US$ Mn), and Share Analysis (%), Forecast Period up to 10 Years
    • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
    • Segment Trends
  • FISH (Fluorescence in Situ Hybridization)
    • Overview
    • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • NGS (Next-Generation Sequencing)
    • Overview
    • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • PCR (Polymerase Chain Reaction)
    • Overview
    • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • IHC (Immunohistochemistry)
    • Overview
    • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  1. Gene Fusion Testing Market, By End-Users, Forecast Period up to 10 Years, (US$ Mn)
    • Overview                                      
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), Forecast Period up to 10 Years
      • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
      • Segment Trends
    • Hospitals
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
    • Diagnostic Laboratories
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
    • Pharmaceutical & Biotechnology Companies
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
    • Academic & Research Centers
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  2. Gene Fusion Testing Market, By Region, Forecast Period up to 10 Years, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), Forecast Period up to 10 Years
      • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
      • Regional Trends
    • North America
      • Market Size and Forecast (US$ Mn), By Indication, Forecast Period up to 10 Years
      • Market Size and Forecast (US$ Mn), By Technology, Forecast Period up to 10 Years
      • Market Size and Forecast (US$ Mn), By End-Users, Forecast Period up to 10 Years
      • Market Size and Forecast (US$ Mn), By Country, Forecast Period up to 10 Years
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast (US$ Mn), By Indication, Forecast Period up to 10 Years
      • Market Size and Forecast (US$ Mn), By Technology, Forecast Period up to 10 Years
      • Market Size and Forecast (US$ Mn), By End-Users, Forecast Period up to 10 Years
      • Market Size and Forecast (US$ Mn), By Country, Forecast Period up to 10 Years
        • UK
        • France
        • Germany
        • Russia
        • Italy
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast (US$ Mn), By Indication, Forecast Period up to 10 Years
      • Market Size and Forecast (US$ Mn), By Technology, Forecast Period up to 10 Years
      • Market Size and Forecast (US$ Mn), By End-Users, Forecast Period up to 10 Years
      • Market Size and Forecast (US$ Mn), By Country, Forecast Period up to 10 Years
        • India
        • Japan
        • South Korea
        • China
        • Rest of Asia Pacific
    • Latin America
      • Market Size and Forecast (US$ Mn), By Indication, Forecast Period up to 10 Years
      • Market Size and Forecast (US$ Mn), By Technology, Forecast Period up to 10 Years
      • Market Size and Forecast (US$ Mn), By End-Users, Forecast Period up to 10 Years
      • Market Size and Forecast (US$ Mn), By Country, Forecast Period up to 10 Years
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
    • Market Size and Forecast (US$ Mn), By Indication, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Mn), By Technology, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Mn), By End-Users, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Mn), By Country, Forecast Period up to 10 Years
  • GCC
  • Israel
  • South Africa
  • Rest of Middle East
  1. Competitive Landscape
    • Heat Map Analysis
    • Market Presence and Specificity Analysis

FAQs

The Gene Fusion Testing Market is segmented into Indication, Technology, End-Users and Region.

Gene Fusion Testing Market is driven by factors like growing prevalence of cancer diseases.

The key players operating the Gene Fusion Testing Market includes, Amoy Diagnostics Co. Ltd., Arima Genomics, F. Hoffman-La Roche Ltd., ArcherDX, Biocartis, Illumina, Danaher Corporation, Guardant Health, Biocare Medical LLC., and Myriad Genetics Inc.

Gene Fusion Testing Market accounted for US$ 255.3 million in 2022 and is estimated to be US$ 794.0 million by 2032 and is anticipated to register a CAGR of 12.5%.